U.S. Congress - S.1695 Biologics Price Competition and Innovation Act of 2007
S.1695 - Biologics Price Competition and Innovation Act of 2007
A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. view all titles (2)
All Bill Titles
- Short: Biologics Price Competition and Innovation Act of 2007 as introduced.
- Official: A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
- Newest First
- Oldest First
- Highest Rated
Sort By
News Coverage
Senate Committee Passes Follow-On ...
The Biologics Price Competition and Innovation Act, S. 1695, allows the FDA to use its scientific discretion in approving products that a...
Panel OKs Bill to Spur Generic Ver...
... amendments from both sides, preserving what they described as a delicate compromise on the legislation ( S 1695 ), which was approved...
Blog Coverage
S.1695: A bill to authorize the aw...
Official government data, breaking news and blog coverage, public comments and user community for S.1695 A bill to authorize the award of...
Patent Docs: Top Stories of 2008: ...
Five follow-on biologics bills were introduced during the 110th Congress: H.R. 1956 (which provides twelve years of data exclusivity and ...
Patent Docs: Teva CEO Predicts Pas...
We also reported last summer that the Biotechnology Industry Organization (BIO) indicated that either H.R. 1956 (providing fourteen years...
GoozNews: Biosimilars, Biogenerics...
Ted Kennedyâs S.1695, Sen. Judd Greggâs S.1505 and Rep. Anna Eshooâs H.R.5629 each call for testing drugs for safety, purity and â...
The Sietch Blog » General Motors:...
Bills targeted include: Climate change (S.2191), CAFE (H.R.5560, S.2555), Biogenerics Legislation (S.1695 et al), Railroad Antitrust Enfo...
Patent Baristas » Economist Argue...
S. 1695, sponsored by Senators Kennedy, Enzi, Clinton and Hatch, would allow for 12 years of data exclusivity. H.R. 5629, sponsored by Re...
Bio Pharma Bonanza » Blog Archive...
S. 1695, sponsored by Senators Kennedy, Enzi, Clinton and Hatch, would allow for 12 years of data exclusivity. H.R. 5629, sponsored by Re...
General Motors: Emptying The Ocean...
Bills targeted include: Climate change (S.2191), CAFE (HR5560, S.2555), Biogenerics Legislation (S.1695 et al), Railroad Antitrust Enforc...
HTA Blog: Waxman: FOBs Would Ensur...
which provides for 14 years; and S. 1695, introduced by Sens. Edward Kennedy (D-Mass.), Orrin Hatch (R-Utah), Michael Enzi (R-Wyo.) and C...
Biosimilar Bill Reported From Sena...
Bipartisan legislation (S. 1695 (the Biologics Price Competition and Innovation Act)) that would create a mechanism for FDA approval of "...
Vote on This Bill
-
Share This Bill
More Share via Email
